A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in ...

For women who undergo a mastectomy, reconstruction is treated almost as a given. We speaks to seven women proudly defying the status quo.

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients ...

Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients can interact and drive resistance to certain drugs ...

A new Australian artificial intelligence tool could transform breast cancer screening by offering a more personalised and ...

An artificial intelligence (AI) algorithm used to detect breast cancer in screening scans has been adapted into a risk score ...

A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center report that ...

The integration of genomic testing into cancer screening enables diagnostics to break away from conventional, one-size-fits-all protocols.

A guide to Medicare coverage for breast cancer diagnosis and treatment, including cost differences between Original Medicare ...

A new study examined whether AI could help us predict breast cancer risk. Two experts unpack its key findings.